MSD
The Drug Metabolism and Pharmacokinetics (DMPK) group is seeking a scientist to support preclinical therapeutic development through integrated drug disposition and pharmacology. This role involves planning and conducting in vitro/ex vivo studies for biologics, interpreting complex experimental data, and collaborating with multidisciplinary teams to inform pipeline decisions.
At MSD, we're following the science to tackle some of the world's greatest health threats. Get a glimpse of how we work to improve lives.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for MSD.
MSD ends takeover talks with Revolution Medicines
1 month ago